Publisher
Springer Berlin Heidelberg
Reference30 articles.
1. Bailey G, Vaughan L, Rose C, Krambeck A (2016) Perinatal outcomes with Tamsulosin therapy for symptomatic urolithiasis. J Urol 195(1):99–103. https://doi.org/10.1016/j.juro.2015.06.097. PMID: 26144335
2. Chen K, Mi H, Xu G, Liu L, Sun X, Wang S, Meng Q, Lv T (2015) The efficacy and safety of Tamsulosin combined with extracorporeal shockwave lithotripsy for urolithiasis: a systematic review and meta-analysis of randomized controlled trials. J Endourol 29:1166–1176
3. Davenport K, Timoney AG, Keeley FX (2006) A comparative in vitro study to determine the beneficial effect of calcium-channel and alpha(1)-adrenoceptor antagonism on human ureteric activity. BJU Int 98(3):651–655. CrossRef PubMed
4. Davenport K, Timoney AG, Keeley FX (2007) Effect of smooth muscle relaxant drugs on proximal human ureteric activity in vivo: a pilot study. Urol Res 35(4):207–213. CrossRef PubMed
5. G-BA (2019) Beschluss des Gemeinsamen Bundesausschusses über eine Änderung der Arzneimittel- Richtlinie (AM-RL): Anlage VI – Off-Label-Use Tamsulosin bei Urolithiasis (als medikamentöse expulsive Therapie auch nach Lithotripsie), in BAnz AT 17.06.2019 B1. Gemeinsamer Bundesausschuss: Berlin